Cho, Y.W., Belej, M., Aviado, D.M.: Pharmacology of a New Antianginal drug: Perhexiline I. Coronary circulation and Myocardial Metabolism, Chest58: 577, 1970.
3.
Matsuo, S., Cho, Y.W., Aviado, D.M.: Pharmacology of a new antianginal drug: Perhexiline. II. Heart rate and transmembrane potential of Cardiac tissue, Chest58: 581, 1970.
4.
Feinsilver, O., Chow, Y.W., Aviado , D.M.: Pharmacology of a new antianginal drug: Perhexiline, III. Bronchopulmonary system in the dog and Humans, Chest58: 558, 1970.
5.
De Oliverira, J.M., Amado, Newton, J.A.: Perhexiline Maleate in the treatment of Angina Pectoris. O. Hospital77: 1511, 1970.
6.
Grupp, I.L., Bunde, C.A., Grupp, G.: Effects of Perhexiline Maleate on Exercise-induced tachycardiaJ. Clinical Pharmacol10: 312, 1970.
7.
Winsor, T.: Clinical evaluation of Perhexiline Maleate, Clin. Pharmacol Therap11: 85, 1970.
8.
Datey, K.K. and Dalvi, C.P.: Antianginal drugs. Their evaluation by double blind trial. Angiology21: 520, 1970.
9.
Devies, P., Oram, S. and Curwen, M.P.: Double blind trial of Benziodarone in angina pectoris. Br. Med. J.2: 359-361, 1963.
10.
Ginn, W.M. Jr. and Orgain, E.S. : Propranolol Hydrochloride in the treatment of Angina Pectoris. J.A.M.A.198: 1214, 1966 .
11.
Jacobsson, K.A., Koch, G., Lavander-Lindgren , M.; and Michaelsson, G.: Double Blind trial with Prenylamine (Segontin) in coronary insufficiency. Acta Med. Scand.180: 129, 1966.
12.
Keelan, P.: Double Blind Trial of Propranolol (Inderal) in Angina Pectoris, BMJI: 897. 1965.
13.
Kerridge, D.F. , Muzurkie, S.J., and Verel, D.: A Clinical trial of Prenylamine Lactate—A long lasting coronary dilator drug: Can. Med. Ass. Jour.85: 1352, 1961.
14.
Lieberman, A. and Guglielmelli , S.: Persantin—A double blind study. Angiology15: 290, 1964.
15.
Newhouse, M.T. and McGregor, M.: Long Term Dipyridamole Therapy of Angina Pectoris, A., Jr. Cardiol.16: 234, 1965.
16.
Russek, H.I. : The Therapeutic role of Coronary Vasodilators—Glyceryl trinitrate, Isosorbide dinitrate or Pentaerythretol Tetranitrate. Am. J. Med. Sc.252: 9, 1966.
17.
Sosa, J.A., McGregor, M.: Prenylamine in Angina Pectoris. Can. Med. Ass. Jour.89: 248, 1963.
18.
Srivastava, S.C. , Dewar, H.A., Newell , D.J.: Double blind trial of Propranolol (Inderal) in Angina of Effort. BMJ2: 724, 1964.
19.
Wirecki, M.: Treatment of Angina Pectoris with Dipyridamole—A long-term double blind study. J. Chron. Dis.20: 139, 1967.
20.
Datey, K.K. and Dalvi, C.P.: A New Approach to the Evaluation of Anti-Anginal Drugs. (With special reference to Perhexiline Maleate)Indian Heart Journal25: 3-8, 1973.
21.
Friedberg, C.K.: Diseases of the heart—4th Edition W. B. Saunders Company, Philadelphia and London1970.
22.
Pardee, H.E.B. et al: Nomenclature and criteria for diagnosis of diseases of the heart and blood vessels. New York Heart Association, 1953.
23.
Datey, K.K., and Dalvi, C.P.: Isosorbide dinitrate ('Sorbitrate') A new antianginal drug. J. Assn. Phys. Ind.12: 635-642, 1964.
24.
Burns-Cox, C.J. , Chandrashekhar, K.P., Ikram , H., Peirce, T.H., Pilcher, J., Quinlan, C.D.M., Rees, J.R.: Clinical evaluation of Perhexiline Maleate in patients with angina pectoris. BMJ.4: 586, 1971.
25.
Lyon, L.J., Nevins, M.A., Fisch, S., Henry, S.: Perhexiline Maleate in the treatment of Angina Pectoris, LancetI: 1272, 1971.
26.
Hirshleifer, I.: Perhexiline Maleate in the treatment of Angina Pectoris, Curr Therap Res. 11: 99, 1969.